A Phase I, open label trial in healthy subjects to evaluate the central nervous receptor occupancy of pipamperone at the 5-HT2A and D2 receptor by means of Positron Emission Tomography.

A Phase I, open label trial in healthy subjects to evaluate the central nervous receptor occupancy of pipamperone at the 5-HT2A and D2 receptor by means of Positron Emission Tomography. - Pipamperone PET study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON34843

Enrollment

Registered

2009-12-15

Start date

2009-12-22

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression major depressive disorder

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy males and females Between 35 and 75 years of age

Exclusion criteria

Exclusion criteria: Clinical significant abnormalities for medical examination

Design outcomes

Primary

Measure	Time frame
-	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results